Susanne Graslund

Karolinska Institutet
Country flagSweden

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Articles (3)

Year:

2026

Objectives Autoantibodies targeting melanoma differentiation associated protein 5 (MDA5) are strongly associated with dermatomyositis (DM) and may contribute to its pathogenesis. Here we aimed to investigate MDA5 + B cells, their phenotype and generate MDA5 monoclonal antibodies to assess their epitope specificity. Methods MDA5-reactive B cells were captured from peripheral blood of patients with anti-MDA5 + DM (n=3) using an MDA5-fluorescent probe. B cell receptor (BCR) sequences were analysed from single-sorted B cells (n=240). Selected clones were re-expressed as IgG1 monoclonal antibodies (mAbs, n=23). Reactivity was assessed using recombinant MDA5 protein constructs, peptide epitope mapping, ELISA, western blot and a commercial line blot assay. Results Of 240 anti-MDA5 + sorted B cells, 23 BCRs were re-expressed as mAbs, two of which showed high reactivity and specificity for MDA5. These antibody sequences originated from one CD19 + IgD - CD27 - CD38 + and one CD19 + IgD - CD27 + CD38 + IgG + B cell with low somatic hypermutation (SHM). Both mAbs had nanomolar apparent affinity and bound to sites within the helicase domains of the MDA5 protein but with distinct epitope recognition. Serology screening confirmed targeting of a linear epitope identified in the mAb studies. Conclusion Our results show that anti-MDA5 + B cells recognize the helicase domains, which are the enzymatically active domains of the protein. These results have implications for understanding the etiopathology of anti-MDA5 + DM and development of new antigen-specific therapies.

Year:

2025

Genetic studies have identified hundreds of risk genes for neurodegenerative diseases, yet translating these variants into disease mechanisms remains limited by incomplete knowledge of the protein products. Here, we present the ALS-Reproducible Antibody Platform (ALS-RAP), a systematic effort to characterize 303 antibodies targeting 33 amyotrophic lateral sclerosis (ALS) risk genes: ACSL5, ALS2, ANG, ANXA11, ATXN2, C9orf72, CAV1, CCNF, CHCHD10, CHMP2B, FIG4, FUS, HNRNPA1, HNRNPA2B1, KIF5A, LGALS1, MATR3, NEK1, OPTN, PFN1, SETX, SIGMAR1, SOD1, SPG11, SQSTM1, TAF15, TARDBP, TBK1, TIA1, TUBA4A, UBQLN2, VAPB, and VCP using knockout-based characterization to identify high-quality reagents in common applications. Using these antibodies, we profiled protein expression across human iPSC-derived and primary neurological cell types. Protein-level analyses revealed diverse cell type-specific expression patterns, with subsets of ALS-associated proteins enriched in glial or neuronal populations. This work provides a validated antibody toolbox and ALS protein resource for translating genetic risk into mechanistic insights.

Year:

2025

Collaborators (19)

Carolyn Marks

Karolinska Institutet

SWEDEN
View details

Thomas M. Durcan

Associate Professor

Montreal Neurological Institute and Hospital

CANADA
View details

Charlotta Preger

Karolinska Institutet

SWEDEN
View details

Luke Michael Healy

-

CANADA
View details

Peter S. McPherson

McGill University

CANADA
View details

Ingrid Lundberg

Professor

Karolinska Institutet

SWEDEN
View details

Carl Laflamme

Assistant Professor

University of Ottawa

CANADA
View details

Karine Chemin

Associate Professor at Karolinska Institutet

Karolinska Institutet

SWEDEN
View details

Opher Gileadi

Head, Protein Sciences

Karolinska Institutet

SWEDEN
View details

Helena Idborg

Karolinska Institutet

SWEDEN
View details

Edward A. Fon

Professor

Montreal Neurological Institute and Hospital

CANADA
View details

Elisabet Svenungsson

Karolinska Institutet

SWEDEN
View details

Radiosa Gallini

Uppsala University

SWEDEN
View details

Vijay Joshua

Karolinska Institutet

SWEDEN
View details

Vivianne Malmström

Professor at Karolinska Institutet

Karolinska Institutet

SWEDEN
View details

Guy A Rouleau

Professor

McGill University

CANADA
View details

Brian D. Marsden

Associate Professor, Research Informatics

University of Oxford

UNITED KINGDOM
View details

Begum Horuluoglu

Assistant Professor

Karolinska Institutet

SWEDEN
View details

Harvinder Virk

NIHR Academic Clinical Lecturer (Respiratory Medicine)

University of Leicester

UNITED KINGDOM
View details